Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) – Sinophi agreement with Jilin University

Advanced Oncotherapy (AVO) – Sinophi agreement with Jilin University

AVO1Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, confirms that its partner for the Chinese market, Sinophi Healthcare Limited, has recently signed a Framework Agreement with China-Japan Union Hospital of Jilin University in relation to a proton therapy centre.

Advanced Oncotherapy confirms that this Framework Agreement does not as yet constitute a purchase order for a LIGHT machine, but should a purchase order be received by the Company it will notify shareholders in accordance with AIM disclosure rules.

Advanced Oncotherapy Plc


Sanjeev Pandya, CEO

Tel: +44 20 3617 8728

Nicolas Serandour, CFO

Westhouse Securities (Nomad & Joint Broker)

Antonio Bossi / David Coaten

Tel: +44 20 7601 6100

Beaufort Securities (Joint Broker)

Jon Levinson / Zoe Alexander

Tel: +44 20 7382 8300

Walbrook PR (Financial PR & IR)

Tel: +44 20 7933 8780 or avo@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 7980 541 893 / Mob: +44 7876 741 001


Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.